BamSEC and AlphaSense Join Forces
Learn More

MGI GP, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 425 5 pages July 20, 2005 Confidential Paul Royalty Fund, L.P. Paul Royalty Fund Holdings II C/O Paul Capital Management, L.L.C. 50 California Street Suite 3000 San Francisco, Ca 94111 Attention: Chief Financial Officer Walter Flamenbaum, M.D. Mr. Lionel Leventhal Paul Capital Partners 140 East 45th Street, 44th Floor New York, Ny 10017 Ladies and Gentlemen
12/34/56
EX-10.2
from 8-K 5 pages July 20, 2005 Confidential Paul Royalty Fund, L.P. Paul Royalty Fund Holdings II C/O Paul Capital Management, L.L.C. 50 California Street Suite 3000 San Francisco, Ca 94111 Attention: Chief Financial Officer Walter Flamenbaum, M.D. Mr. Lionel Leventhal Paul Capital Partners 140 East 45th Street, 44th Floor New York, Ny 10017 Ladies and Gentlemen
12/34/56
EX-10.3
from 425 4 pages July 20, 2005 Confidential
12/34/56
EX-10.2
from 425 1 page The Validity, Construction and Enforceability of This Note Shall Be Governed by the Internal Laws of the State of New York Without Giving Effect to the Conflict of Laws Principles Thereof. Guilford Pharmaceuticals Inc. By: /S/ Dean J. Mitchell Title: President and Chief Executive Officer
12/34/56
EX-10.1
from 8-K ~5 pages This Is a Release. You Should Read It Carefully Before You Sign It. Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K ~5 pages Guilford Pharmaceuticals Inc. Employee Retention Plan
12/34/56
EX-10.30D
from 10-K 9 pages Third Amendment to License Agreement
12/34/56
EX-10.30C
from 10-K 8 pages Second Amendment to the License Agreement
12/34/56
EX-10.30B
from 10-K 5 pages First Amendment to the License Agreement
12/34/56
EX-10.30A
from 10-K 28 pages License, Development and Commercialization Agreement
12/34/56
EX-10.1
from 8-K ~1 page Guilford Pharmaceuticals Inc. 2002 Stock Award and Incentive Plan Employee Stock Unit Agreement
12/34/56
EX-10..2
from 8-K ~20 pages Amended and Restated Single Tenant Absolute Net Lease
12/34/56
EX-10..1
from 8-K ~20 pages Amended and Restated Single Tenant Absolute Net Lease
12/34/56
EX-10.42
from 10-Q/A 52 pages Manufacturing and Supply Agreement by and Between Guilford Pharmaceuticals Inc. and Baxter Healthcare Corporation
12/34/56
EX-10.02
from 8-K ~10 pages Material contract
12/34/56
EX-10.01
from 8-K ~50 pages Material contract
12/34/56
EX-10.43
from 10-Q 4 pages Guilford Pharmaceuticals Inc. 2002 Stock Award and Incentive Plan Director Stock Unit Agreement
12/34/56
EX-10.01
from 8-K 11 pages Guilford Pharmaceuticals Inc. Compensation Plan for Outside Directors
12/34/56
EX-10.1
from 8-K 17 pages Consulting Services and Separation Agreement
12/34/56
EX-10.42
from 10-Q 52 pages Manufacturing and Supply Agreement by and Between Guilford Pharmaceuticals Inc. and Baxter Healthcare Corporation *The Asterisk Denotes That Confidential Portions of This Exhibit Have Been Omitted and Submitted Separately to the Securities and Exchange Commission
12/34/56